Intratumoral inflammation is associated with more aggressive prostate cancer

被引:0
作者
Joseph C. Klink
Lionel L. Bañez
Leah Gerber
Amy Lark
Robin T. Vollmer
Stephen J. Freedland
机构
[1] Veterans Affairs Medical Center,Urology Section, Department of Surgery
[2] Duke University Medical Center,Division of Urologic Surgery and the Duke Prostate Center, Department of Surgery
[3] Veterans Affairs Medical Center,Department of Pathology
[4] Duke University Medical Center,Department of Pathology
[5] Cleveland Clinic,Glickman Urological and Kidney Institute
来源
World Journal of Urology | 2013年 / 31卷
关键词
Inflammation; Prostate cancer; Radical prostatectomy; Adverse pathology; Biochemical progression;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1497 / 1503
页数:6
相关论文
共 74 条
[11]  
Mahmud SM(2007)Genetic variability in inflammation pathways and prostate cancer risk Urol Oncol 25 250-259
[12]  
Franco EL(2011)Inflammation, focal atrophic lesions, and prostatic intraepithelial neoplasia with respect to risk of lethal prostate cancer Cancer Epidemiol Biomarkers Prev 20 2280-2287
[13]  
Aprikian AG(2000)Inflammatory infiltrate (prostatitis) in whole mounted radical prostatectomy specimens from black and white patients is not an etiology for racial difference in prostate specific antigen J Urol 163 131-136
[14]  
Jafari S(1997)Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value J Urol 157 1301-1303
[15]  
Etminan M(1999)High-grade inflammation in prostate cancer as a prognostic factor for biochemical recurrence after radical prostatectomy. Pathologist multi center study group Urology 54 467-472
[16]  
Afshar K(2004)The relationship between T-lymphocyte subset infiltration and survival in patients with prostate cancer Br J Cancer 91 541-543
[17]  
Jacobs EJ(2011)Infiltration of tumour-associated macrophages in prostate biopsy specimens is predictive of disease progression after hormonal therapy for prostate cancer BJU Int 107 1918-1922
[18]  
Thun MJ(2009)Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer Cancer 115 3670-3679
[19]  
Bain EB(2006)Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality J Urol 176 1404-1408
[20]  
Rodriguez C(undefined)undefined undefined undefined undefined-undefined